Asteroid Menthol, Petrolatum, Zinc Oxide .098 g/28g; 22.302 g/28g; 1.4 g/28g Ointment — NDC 84107-0552-02 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Asteroid Menthol, Petrolatum, Zinc Oxide .098 g/28g; 22.302 g/28g; 1.4 g/28g Ointment — NDC 84107-552-02 (Billing 84107-0552-02)

by HEALTHTEX LIMITED · 1 TUBE in 1 CARTON / 28 g in 1 TUBE

This is a package of Asteroid Menthol, Petrolatum, Zinc Oxide .098 g/28g; 22.302 g/28g; 1.4 g/28g Ointment from HEALTHTEX LIMITED, marketed since Jul 2025 and currently FDA-listed. It is this product's only package size.

NDC 84107-0552-02
🏷️ FDA NDC (as labeled) 84107-552-02 billing pads the product segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 84107-552-02
Product NDC 84107-552
11-digit billing NDC 84107055202
RxCUI 2720028
UNII L7T10EIP3A, 4T6H12BN9U, SOI2LOH54Z
UPC 9413000113440
Application # M015
SPL Set ID 29d1e46d-0189-4f9e-9963-8a9de2757f28
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2025-07-22
Route TOPICAL
Dosage form OINTMENT
Substance MENTHOL; PETROLATUM; ZINC OXIDE
Quick answers
  • RxCUI (RxNorm): 2720028
Why two NDCs? The FDA registers this code as 84107-552-02 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 84107-0552-02. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

🧪 What is this product?

Asteroid Menthol is a topical ointment sold over the counter under FDA monograph rules for skin care products. It contains menthol, which is typically used to produce a cooling sensation and mild numbing effect on the skin, along with petrolatum and zinc oxide, which function as moisturizers and skin protectants. This combination is commonly used to soothe minor skin irritation and help protect the skin barrier.

Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
84107-0552-02 You're viewing this Main listing 1 TUBE in 1 CARTON / 28 g in 1 TUBE 2025-07-22 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Asteroid .098 g/28g; 22.302 g/28g; 1.4 g/28gthis 84107-0552-02 HEALTHTEX 1 tube — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2025
On the market since
Jul 2025
📍
2026
Currently FDA-listed
1 year listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 512OYT1CRR
    Cocoa butter is a natural fat extracted from cocoa beans. It's used in medicines as a base for suppositories and as a lubricant to help pills dissolve smoothly.

1 inactive ingredient listed in the exact product block matched to this NDC.

The official label also statesCocoa Butter, Petrolatum.

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerHEALTHTEX LIMITED
FDA applicationM015 (OTC MONOGRAPH DRUG)
Labeler code84107
First marketedJul 2025
Product typeHuman Otc Drug
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 21 words ▾

Uses helps relieve burning, soreness, and itching by providing rapid acting cooling barrier ointment for external hemorrhoids and minor anal irritation.

⏱️ Dosage and Administration 24 words ▾

Directions Adults: Apply externally to the affected area up to 4 times daily, especially at night, in the morning or after each bowel movement.

⚠️ Warnings 124 words ▾

Warnings For external use only. Do Not Use Do not use if you are bleeding from the anal region. When using this product Do not exceed the recommended daily dosage unless directed by the doctor.

Do not put into rectum by using fingers or any mechanical device or applicator. Possible side effects may include a brief cooling or heating sensation on application. Stop use and ask a doctor if If allergic to the ointment or any of it's ingredients Bleeding occurs in the anal region Condition worsens or does not improve within 7 days.

If pregnant or breast-feeding Do not use if pregnant or breastfeeding. Keep out of reach of children If swallowed, get medical help, or contact a Poison Control Center right away.

🧪 Active Ingredient 9 words ▾

Active Ingredients Menthol 0.35% Petrolatum 79.65% Zinc Oxide 5.00%

🧪 Inactive Ingredients 5 words ▾

Inactive ingredients Cocoa Butter, Petrolatum.

🎯 Purpose 4 words ▾

Purposes Anesthetic/Antipruritic/Analgesic Protectant Astringent

📄 Do Not Use 14 words ▾

Do Not Use Do not use if you are bleeding from the anal region.

📄 When Using This Product 43 words ▾

When using this product Do not exceed the recommended daily dosage unless directed by the doctor. Do not put into rectum by using fingers or any mechanical device or applicator. Possible side effects may include a brief cooling or heating sensation on application.

📄 Stop Use and Ask a Doctor If 32 words ▾

Stop use and ask a doctor if If allergic to the ointment or any of it's ingredients Bleeding occurs in the anal region Condition worsens or does not improve within 7 days.

🤰 If Pregnant or Breast-Feeding 11 words ▾

If pregnant or breast-feeding Do not use if pregnant or breastfeeding.

📄 Keep Out of Reach of Children 19 words ▾

Keep out of reach of children If swallowed, get medical help, or contact a Poison Control Center right away.

📄 Other Information 8 words ▾

Other information Store at room temperature 68°-77°F (20°-25°C)

📄 Questions or Comments 5 words ▾

Questions? 1-800-819-9676 or visit neoqura.com

📄 Package Label / Principal Display Panel 95 words ▾

Principal Display Panel – 28 g Carton Label NDC 84107-552-02 neoqura asteroid™ ointment Hemorrhoid formulation Rapid acting cooling barrier ointment for burning soreness and itching associated with external hemorrhoids and minor anal irritation. + COOLS + SOOTHES + PROTECTS 1 TUBE | NET WT

1.0 OZ (28 g) Figure

Principal Display Panel – 28 g Tube Label neoqura asteroid™ ointment Hemorrhoid formulation Rapid acting cooling barrier ointment for burning soreness and itching associated with external hemorrhoids and minor anal irritation. + COOLS + SOOTHES + PROTECTS 1 TUBE NET WT

1.0 OZ (28 g) Figure

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by HEALTHTEX LIMITED. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
HEALTHTEX LIMITED is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.